Abstract:This paper describes the systematic development of green and sustainable HPLC method for quantification of antidiabetic drugs teneligliptin hydrobromide hydrate, metformin hydrochloride and pioglitazone HCl in tablet formulation using Box–Behnken design. Box–Behnken design was used to know the influence of identified critical method parameters, volume of acetonitrile, flow rate and column temperature on the retention time of all three drugs and resolution between two drugs. Statistical analysis by Analysis of variance was computed to understand the potential interactions among critical method parameters. Further mathematical model was validated by using statistical and graphical optimization to define the design space. From the three parameters under investigation the study revealed that the response was more influenced by slight change in volume of acetonitrile, demanding its strict control. A mixture of KH 2 PO 4 phosphate buffer (20 mM): acetonitrile: methanol (40:30:30%v/v) was employed as the mobile phase for chromatographic separation using octadecyl silyl column (250 × 4.6 mm, 5 μm). Detection was performed at 236 nm and 0.86 ml/min was set as the flow rate of mobile phase. The linearity was observed in the range of 12–28 μg/ml for Teneligliptin hydrobromide hydrate, 300–700 μg/ml for Metformin hydrochloride and 9–21 μg/ml for Pioglitazone hydrochloride as shown by r 2 ≥ 0.99 for all three drugs. Retention time of Teneligliptin hydrobromide hydrate, Metformin hydrochloride and Pioglitazone hydrochloride was 4.09, 3.01 and 11.44 min, respectively. The % relative standard deviation for accuracy, precision and robustness were all within the specification, less than 2, which indicates that method was validated properly as per guideline. The studies successfully demonstrate the application of Box–Behnken design in the development of accurate and sensitive liquid chromatographic technique with enhanced method performance. Furthermore, greenness of the analytical method was assessed using 12 principles of green analytical chemistry by AGREE, complex GAPI and Analytical eco-scale tool, indicating that the developed method was ecofriendly.

Green synthesis, spectroscopic and theoretical studies on molecular charge-transfer complex of linagliptin with 2, 3-dichloro-5,6-dicyano-1,4-benzoquinone, chloranilic acid and ninhydrin

Response Surface Methodology in Spectrophotometric Estimation of Saxagliptin, Derivatization with MBTH and Ninhydrin

Development of eco-friendly spectrophotometric methods for analysis of metformin hydrochloride and linagliptin in presence of metformin toxic impurity in their pure and dosage forms: Validation, practicality and greenness studies

Synthesis of 1,2,3-Triazole Analogs of Linagliptin as Novel DPP-4 Inhibitors: DFT, Molecular Docking Approach

Application of isoindole fluorophore formation for determination of linagliptin in the sole and co-formulated tablets: Application for plasma assay and content uniformity testing

Spectrofluorimetric determination of Alogliptin benzoate through condensation with ninhydrin and phenylacetaldehyde: application to dosage form and rat plasma

Synthesis, Characterization, In Silico DFT, Molecular Docking, and Dynamics Simulation Studies of Phenylhydrazono Phenoxyquinolones for Their Hypoglycemic Efficacy

Ultrasound-assisted synthesis of 4-thiazolidinone Schiff bases and their antioxidant, α-glucosidase, α-amylase inhibition, mode of inhibition and computational studies

Synthesis, spectroscopic, thermal, structural investigations and biological activity studies of charge-transfer complexes of atorvastatin calcium with dihydroxy-p-benzoquinone, quinalizarin and picric acid

Green metrics-based HPLC method for quantification of three antidiabetic drugs in tablet dosage form using Box–Behnken design

Green quantitative methods for linagliptin and empagliflozin in dosage forms

Quinoline Based thiazolidinediones: Design, Synthesis, In Silico, In Vitro, Antioxidant and Antidiabetic Evaluation

Synthesis, molecular docking, enzyme inhibition and antioxidant potential of new 1H-benzo[ d ]imidazole-5-carboxamide derivatives

Investigation on synthesized sulfonamide Schiff base with DFT approaches and in silico pharmacokinetic studies: Topological, NBO, and NLO analyses

Experimental and Theoretical Studies for I⋯F, I⋯I and I⋯N Intermolecular Interactions Analysis in 5, 7-diiodoquinoline derivatives and their In-vitro DPP-4 inhibitory activity

Green synthesis, molecular docking and in vitro biological evaluation of novel hydrazones, pyrazoles, 1,2,4-triazoles and 1,3,4-oxadiazoles

Quinoline-based Schiff bases as possible antidiabetic agents: ligand-based pharmacophore modeling, 3D QSAR, docking, and molecular dynamics simulations study

Synthesis, X-ray diffraction analysis, quantum chemical studies and α-amylase inhibition of probenecid derived S-alkylphthalimide-oxadiazole-benzenesulfonamide hybrids

Glutamic acid-catalyzed synthesis of dihydroquinazolinone: anticancer activity, electrochemical behavior, molecular docking, dynamics, simulations and drug-likeness studies

Box–Behnken Design-Based Optimized Kinetic Approach to Develop an Eco-friendly Analytical Method for the Quantitation of Glimepiride Using Spectrophotometry

Stability-Indicating TLC-Densitometric and HPLC Methods for Simultaneous Determination of Teneligliptin and Pioglitazone in Pharmaceutical Dosage Forms with Eco-Friendly Assessment